In this article, we discover several examples of “digital therapeutics”. Even if this new kind of drugs is not so new, first were used 10 years ago, we have seen a lot of new solutions in the previous 2 or 3 years. More and more clinical trials are ongoing and most of the biggest pharmaceuticals industries work on it. Authors describe the history of this domain and explain in particular links with more classical drugs…"The emerging world of digital therapeutics"
In this article, you will find many examples where “in silico” methods and computing can change biology. In drug discovery, it’s really interesting to see that it allows us to make multiple virtual assays and only synthesize and test only promising compounds. It’s a new era of modeling and simulation, which is accelerating discovery for drugs, vaccines, medical devices, materials, and many other products. For years, simulations have been used for physical systems, to cheaply…"Virtual Medicine for Real Patients"